Results 151 to 160 of about 10,846,594 (333)
Phenotyping Healthcare Use 2–3 Decades Before the First Multiple Sclerosis Demyelinating Event
ABSTRACT Objective Phenotype hospital, physician, and emergency department (ED) visits by diagnoses and specialty up to 29 years pre‐multiple sclerosis (MS) onset versus a matched population without MS. Methods We identified people with MS (PwMS) using population‐based administrative data from Ontario, Canada (1991–2020).
Helen Tremlett+8 more
wiley +1 more source
A 72‐Year‐Old Man With a History of Rheumatoid Arthritis Presenting With Unilateral Eye and Jaw Pain
Annals of Clinical and Translational Neurology, EarlyView.
Mohamad Rani Hassoun, Neena R. Cherayil
wiley +1 more source
ABSTRACT Objective Despite the availability of effective therapies for Multiple Sclerosis (MS), the unpredictable nature of disease progression and the variability in individual treatment outcomes call for reliable biomarkers. This pilot study aims to investigate the potential of plasma circulating microRNAs (miRNAs) as predictive biomarkers for ...
Fortunata Carbone+19 more
wiley +1 more source
The Design of A Rule-based and Event-driven Trust Management Framework [PDF]
Yan Wang+3 more
openalex +1 more source
Information and Communication Technology in Event Management
C. V. Winkle, Jill N. H. Bueddefeld
semanticscholar +1 more source
Detecting rs‐fMRI Networks in Disorders of Consciousness: Improving Clinical Interpretability
ABSTRACT Background Preserved resting‐state functional MRI (rs‐fMRI) networks are typically observed in Disorders of Consciousness (DOC). Despite the widespread use of rs‐fMRI in DOC, a systematic assessment of networks is needed to improve the interpretability of data in clinical practice.
Jean Paul Medina Carrion+15 more
wiley +1 more source
Event Semantic Photo Retrieval Management System based on MPEG-7 [PDF]
Byeongtae Ahn+2 more
openalex +1 more source
Factors for Rituximab Refractoriness in AQP4‐IgG+ NMOSD: A Cohort Study
ABSTRACT Objective Neuromyelitis optica spectrum disorder (NMOSD) is a severe autoimmune condition of the central nervous system (CNS), often associated with aquaporin‐4 antibodies (AQP4‐IgG). Rituximab, a CD20+ B‐cell depleting monoclonal antibody, is widely used as first‐line therapy.
Mariano Marrodan+8 more
wiley +1 more source
Knowledge and attitudes of primary care physicians in the management of patients at risk for cardiovascular events [PDF]
Hamidreza Doroodchi+7 more
openalex +1 more source